news

Posted on: 14 November 2025 A comprehensive programme of new research from the Health Research Board (HRB) Collaborative Doctoral Award (CDA) in Multimorbidity has provided crucial insights and evidence-based solutions to improve healthcare and outcomes for people living with multiple long-term conditions (multimorbidity).

Posted on: 31 October 2025 Two landmark international studies led by Professor Ignacio Martin-Loeches have been recently published in The Lancet and Nature Medicine - placing Irish critical care research firmly on the global stage.

Posted on: 22 October 2025 Researchers from Trinity College, St Patrick's Mental Health Services, Queen's University Belfast, Ireland, investigate use of twice-weekly ketamine infusions as an add-on treatment for inpatients with serious depression Findings from a randomised and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit for ketamine when added onto standard care for people admitted to hospital for depression.

Posted on: 09 October 2025 Researchers wanted to understand how steroids selectively affect human macrophages, which are a key cellular player in the immune response to Mycobacterium tuberculosis (Mtb); the bacteria which causes TB. Tuberculosis (TB) remains a major global health challenge, affecting over 10 million people annually worldwide, with 1.25 million people dying of TB every year.

Posted on: 08 September 2025 An early phase clinical trial published in Nature Medicine show that patients with mesothelioma - a rare cancer of the lining of the lung - who received a combination of two immunotherapy drugs before surgery had successful surgeries and encouraging early outcomes Results from an early phase clinical trial presented this week at the World Conference on Lung Cancer Meeting in Barcelona, Spain, and published in Nature

Study marks a significant milestone in the ongoing battle against antimicrobial resistance, a global public health threat A new groundbreaking large-scale research study from University of Limerick marks a major milestone in the battle against antimicrobial resistance (AMR), a global public health threat that could add a trillion US dollars to worldwide healthcare costs over the next 25 years.

New findings suggest the vaccine may reduce the production of pro-inflammatory mediators to bacterial, fungal or viral infections by reprogramming innate immune cells to regulate inflammation Trinity researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended, primary target.

Weight-loss medications such as Ozempic, Wegovy or Monjaro may not just suppress appetite but could also speed up metabolism. This is according to a new study carried out at St Vincent's University Hospital (SVUH) . A randomized controlled trial led by Professor Donal O'Shea , SVUH and UCD School of Medicine , found that there was a strong relationship between the amount of weight lost and increases in metabolic activity caused by daily use of medications based on the hormone Glucagon-like peptide-1 (GLP-1).